HIV Infection and AIDS in Sub-Saharan Africa: Current Status, Challenges and Opportunities



Ayesha B.M. Kharsany1, *, §, Quarraisha A. Karim1, 2, §
1 Centre for the AIDS Programme of Research in South Africa (CAPRISA), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Private Bag 7, Congella 4013, Durban, South Africa
2 Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, USA


Article Metrics

CrossRef Citations:
0
Total Statistics:

Full-Text HTML Views: 1768
Abstract HTML Views: 2022
PDF Downloads: 311
ePub Downloads: 159
Total Views/Downloads: 4260
Unique Statistics:

Full-Text HTML Views: 547
Abstract HTML Views: 1114
PDF Downloads: 249
ePub Downloads: 115
Total Views/Downloads: 2025



© Kharsany and Karim; Licensee Bentham Open.

open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/legalcode), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.

* Address correspondence to this author at the 2nd Floor, Doris Duke Medical Research Institute, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Private Bag 7, Congella 4013, Durban, South Africa; Tel: +27 31 2604558; Fax: +27 31 2604566; E-mail: ayesha.kharsany@caprisa.org
§ Both authors contributed equally to the preparation of this manuscript.


Abstract

Global trends in HIV infection demonstrate an overall increase in HIV prevalence and substantial declines in AIDS related deaths largely attributable to the survival benefits of antiretroviral treatment. Sub-Saharan Africa carries a disproportionate burden of HIV, accounting for more than 70% of the global burden of infection. Success in HIV prevention in sub-Saharan Africa has the potential to impact on the global burden of HIV. Notwithstanding substantial progress in scaling up antiretroviral therapy (ART), sub-Saharan Africa accounted for 74% of the 1.5 million AIDS related deaths in 2013.

Of the estimated 6000 new infections that occur globally each day, two out of three are in sub-Saharan Africa with young women continuing to bear a disproportionate burden. Adolescent girls and young women aged 15-24 years have up to eight fold higher rates of HIV infection compared to their male peers. There remains a gap in women initiated HIV prevention technologies especially for women who are unable to negotiate the current HIV prevention options of abstinence, behavior change, condoms and medical male circumcision or early treatment initiation in their relationships.

The possibility of an AIDS free generation cannot be realized unless we are able to prevent HIV infection in young women. This review will focus on the epidemiology of HIV infection in sub-Saharan Africa, key drivers of the continued high incidence, mortality rates and priorities for altering current epidemic trajectory in the region. Strategies for optimizing the use of existing and increasingly limited resources are included.

Keywords: Antiretroviral therapy, Biomedical interventions, HIV epidemic, HIV prevention, Sub-Saharan Africa.